Loss of PTEN expression predicts resistance to EGFR-targeted monoclonal antibodies in patients with metastatic colorectal cancer

被引：34
|
作者：
Mao, C. [1 ]
Liao, R-Y [1 ]
Chen, Q. [1 ]
机构：
[1] So Med Univ, Sch Publ Hlth & Trop Med, Dept Epidemiol, Guangzhou, Guangdong, Peoples R China
来源：
BRITISH JOURNAL OF CANCER | 2010年 / 102卷 / 05期
关键词：
D O I：
10.1038/sj.bjc.6605575
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：940 / 940
页数：1
相关论文
共 50 条
  • [41] Molecular Characterization of Acquired Resistance To Anti-EGFR Monoclonal Antibodies in Colorectal Cancer Patients
    Bellosillo, Beatriz
    Dalmases, Alba
    Martinez, Alejandro
    Iglesias, Mar
    Gonzalez, Iria
    Salido, Marta
    Busto, Marcos
    Sanchez, Juan
    Vidal, Joana
    Clave, Sergi
    Moragon, Ester
    Pairet, Silvia
    Bellmunt, Joaquim
    Serrano, Sergio
    Rovira, Ana
    Albanell, Joan
    Montagut, Clara
    MODERN PATHOLOGY, 2015, 28 : 148A - 148A
  • [42] Primary and acquired resistance to EGFR-targeted therapies in colorectal cancer: impact on future treatment strategies
    Leto, Simonetta M.
    Trusolino, Livio
    JOURNAL OF MOLECULAR MEDICINE-JMM, 2014, 92 (07): : 709 - 722
  • [43] Results of monoclonal antibodies against EGFR-receptors application in patients with metastatic colorectal cancer (mCRC).
    Vladimirova, Liubov Yu
    Kit, Oleg Ivanovich
    Nikipelova, Elena A.
    Abramova, Natalya A.
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [44] EGFR status in different stages of resected NSCLC: implications for treatment with EGFR-targeted monoclonal antibodies.
    Berardi, Rossana
    Squadroni, Michela
    Scartozzi, Mario
    Santinelli, Alfredo
    Virdecchia, Lorena
    Valeri, Gianluca
    Gasparini, Stefano
    Marmorale, Cristina
    Fianchini, Aroldo
    Cascinu, Stefano
    ANNALS OF ONCOLOGY, 2007, 18 : 185 - 185
  • [45] Transcriptional modules predicting response of colorectal cancer to EGFR-targeted therapy
    Medico, E.
    Picco, G.
    Isella, C.
    Petti, C.
    EJC SUPPLEMENTS, 2010, 8 (05): : 201 - 201
  • [46] Biomarkers of Resistance to Epidermal Growth Factor Receptor Monoclonal Antibodies in Patients with Metastatic Colorectal Cancer
    Banck, Michaela S.
    Grothey, Axel
    CLINICAL CANCER RESEARCH, 2009, 15 (24) : 7492 - 7501
  • [47] Anti-EGFR monoclonal antibodies in metastatic colorectal cancer: time for an individualized approach?
    Fakih, Marwan
    EXPERT REVIEW OF ANTICANCER THERAPY, 2008, 8 (09) : 1471 - 1480
  • [48] Potential predictive markers of response to EGFR-targeted therapies in colorectal cancer
    Spano, Jean Philippe
    Milano, Gerard
    Vignot, Stephane
    Khayat, David
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2008, 66 (01) : 21 - 30
  • [49] Monoclonal antibodies for targeted therapy in colorectal cancer
    Banerjee, Sreeparna
    Flores-Rozas, Hernan
    CANCER BIOLOGY & THERAPY, 2010, 9 (08) : 563 - 571
  • [50] EGFR gene copy number, KRAS and BRAF status, PTEN and AKT expression analysis in patients with metastatic colon cancer treated with anti-EGFR monoclonal antibodies ± chemotherapy
    Bengala, C.
    Bettelli, S.
    Fontana, A.
    Bertolini, F.
    Sartori, G.
    Malavasi, N.
    Losi, L.
    Del Giovane, C.
    Luppi, G.
    Conte, P.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
12345